In addition, combined panobinostat (10 mg/kg, i.p.)and everolimus (10 mg/kg, p.o.)treatment for 15 days (QD × 7 schedule) showed reduction of tumor proliferation and tumor volume in mice bearing androgen-sensitive as well as castration-resistant Myc-CaP tumors. Here, MYC is linked to neoplasm.